1.
Dermatol Online J
; 23(1)2017 Jan 15.
Article
in English
| MEDLINE
| ID: mdl-28329473
ABSTRACT
We report a 52-year old woman with a 28-year historyof disfiguring facial discoid lupus erythematosus(DLE), persistent despite both classical therapiesand rituximab. Ustekinumab 45 mg was started incombination with methotrexate and intralesionalcorticosteroids. Methotrexate and intralesionalcorticosteroids were withdrawn 30 months later andustekinumab maintained as monotherapy. Fortyeight months later stable improvement was achievedwithout side effects. Only nine patients with cutaneouslupus erythematosus (CLE) treated with ustekinumabhave been reported to date. Ustekinumab could be apromising alternative in severe and recalcitrant casesof CLE. Possibly, the Th17-inflammation pathway isplaying a role in these patients.
Subject(s)
Dermatologic Agents/therapeutic use , Facial Dermatoses/drug therapy , Lupus Erythematosus, Discoid/drug therapy , Ustekinumab/therapeutic use , Adrenal Cortex Hormones/therapeutic use , Facial Dermatoses/pathology , Female , Humans , Immunologic Factors/therapeutic use , Immunosuppressive Agents/therapeutic use , Injections, Intralesional , Lupus Erythematosus, Discoid/pathology , Methotrexate/therapeutic use , Middle Aged , Rituximab/therapeutic use , Treatment Failure
2.
J Am Acad Dermatol
; 81(4): 1023-1024, 2019 10.
Article
in English
| MEDLINE
| ID: mdl-30872152
Subject(s)
Folliculitis , Scalp Dermatoses , Adult , Age of Onset , Anti-Bacterial Agents/therapeutic use , Bacteria/isolation & purification , Biopsy , Chronic Disease , Dermatologic Agents/therapeutic use , Follow-Up Studies , Hair Follicle/microbiology , Hair Follicle/pathology , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Young Adult
3.
An Bras Dermatol
; 93(6): 938-939, 2018.
Article
in English
| MEDLINE
| ID: mdl-30484553
Subject(s)
Antineoplastic Agents, Immunological/adverse effects , Breast Neoplasms/drug therapy , Drug Eruptions/etiology , Maytansine/analogs & derivatives , Telangiectasis/etiology , Trastuzumab/adverse effects , Ado-Trastuzumab Emtansine , Antineoplastic Agents, Immunological/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/chemistry , Drug Eruptions/pathology , Female , Humans , Maytansine/adverse effects , Maytansine/therapeutic use , Middle Aged , Neoplasm Staging , Receptor, ErbB-2 , Telangiectasis/pathology , Trastuzumab/therapeutic use
4.
J Am Acad Dermatol
; 57(2 Suppl): S46-7, 2007 Aug.
Article
in English
| MEDLINE
| ID: mdl-17637374
5.
Med Clin (Barc)
; 145(11): e35, 2015 Dec 07.
Article
in Spanish
| MEDLINE
| ID: mdl-26004278
6.
An. bras. dermatol
; 93(6): 938-939, Nov.-Dec. 2018. graf
Article
in English
| LILACS
| ID: biblio-973636
Subject(s)
Humans , Female , Middle Aged , Telangiectasis/etiology , Breast Neoplasms/drug therapy , Drug Eruptions/etiology , Trastuzumab/adverse effects , Antineoplastic Agents, Immunological/adverse effects , Telangiectasis/pathology , Breast Neoplasms/chemistry , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Drug Eruptions/pathology , Receptor, ErbB-2 , Trastuzumab/therapeutic use , Antineoplastic Agents, Immunological/therapeutic use , Maytansine/analogs & derivatives , Maytansine/adverse effects , Maytansine/therapeutic use , Neoplasm Staging
7.
Int J Dermatol
; 50(8): 921-2, 2011 Aug.
Article
in English
| MEDLINE
| ID: mdl-21781060
Subject(s)
Anetoderma/pathology , Pilomatrixoma/pathology , Skin Neoplasms/pathology , Adult , Anetoderma/surgery , Biopsy , Female , Humans , Pilomatrixoma/surgery , Shoulder , Skin Neoplasms/surgery
8.
Med. clín (Ed. impr.)
; 145(11): 145.e35-145.e35, dic. 2015. ilus
Article
in Spanish
| IBECS (Spain)
| ID: ibc-146507
ABSTRACT
No disponible